Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polyamine analogue antiarrhythmics

R J Bergeron1, J Wiegand, W R Weimar

  • 1Department of Medicinal Chemistry, College of Pharmacy, Gainesville, FL, 32610-0485, USA.

Pharmacological Research
|November 10, 1998
PubMed
Summary

Novel polyamine analogues, particularly tetraamines like PYR(3,3,3), effectively prevent and reverse life-threatening cardiac arrhythmias in rodent models. These compounds show significant antiarrhythmic activity independent of polyamine metabolism modulation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modalities and accuracy of diagnosis of external ventricular drainage-related infections: a prospective multicentre observational cohort study.

Acta neurochirurgica·2018
Same author

Editorial: the impact of steatosis on liver stiffness quantification is minimal-Authors' reply.

Alimentary pharmacology & therapeutics·2018
Same author

Impact of controlled attenuation parameter on detecting fibrosis using liver stiffness measurement.

Alimentary pharmacology & therapeutics·2018
Same author

Highly anisotropic electric conductivity in PAN-based carbon nanofibers.

Journal of physics. Condensed matter : an Institute of Physics journal·2017
Same author

HBsAg and anti-HCV screening in elderly hospitalized patients of a German tertiary referral centre.

Zeitschrift fur Gastroenterologie·2016
Same author

Letter: can persisting liver stiffness indicate increased risk of HCC, after successful anti-HCV therapy?

Alimentary pharmacology & therapeutics·2016

Area of Science:

  • Pharmacology
  • Cardiovascular Research
  • Medicinal Chemistry

Background:

  • Isoproterenol administration in desoxycorticosterone acetate (DOCA)/saline-treated rodents is a standard model for inducing cardiac arrhythmias.
  • Polyamines play crucial roles in cellular processes, and their analogues are explored for therapeutic potential.
  • Understanding structure-activity relationships of polyamine analogues is key to developing novel antiarrhythmic agents.

Purpose of the Study:

  • To evaluate a series of polyamine analogues for their efficacy in preventing and treating isoproterenol-induced ventricular fibrillation and death.
  • To identify specific structural features of polyamine analogues that correlate with antiarrhythmic activity.
  • To investigate the relationship between polyamine metabolism modulation and antiarrhythmic effects.

Related Experiment Videos

Main Methods:

  • Assessment of polyamine analogues in a DOCA/saline rodent model challenged with isoproterenol.
  • Structure-activity relationship analysis of tested polyamine compounds, including antimetabolites and putrescine mimics.
  • Electrocardiographic monitoring to evaluate the protective and reversal effects of compounds on cardiac arrhythmias.

Main Results:

  • Tetraamines dicationic at physiological pH with terminal pyridine rings exhibited the highest antiarrhythmic activity.
  • The most potent polyamine antimetabolites were ineffective as antiarrhythmics, indicating no correlation with polyamine metabolism.
  • N1,N3-bis(4-pyridyl)-1,3-diaminopropane (PYR(3,3,3)) demonstrated significant ability to prevent and reverse isoproterenol-induced arrhythmias, similar to propranolol.
  • Cardiac pathology in PYR(3,3,3) and propranolol treated rats differed markedly from controls.

Conclusions:

  • Specific polyamine analogues, notably PYR(3,3,3), possess potent antiarrhythmic properties.
  • The antiarrhythmic efficacy of these compounds is independent of their influence on polyamine metabolism.
  • PYR(3,3,3) represents a promising lead compound for developing new treatments for cardiac arrhythmias.